The Hidden Cost of Sample Splitting in PCR, and Why It Matters for Low-Input DNA

Many PCR workflows turn one biological sample into many separate reactions

Many PCR workflows measure multiple targets by running separate assays.

A sample may be tested for several mutations, genes, or markers, each in its own reaction. At first glance this seems straightforward: extract the DNA and run the necessary assays.

But when DNA input is limited, this common workflow introduces a subtle statistical and practical challenge.

Every assay draws molecules from the same underlying sample. As the number of assays increases, laboratories must either:

• Use more total sample, or

• Reduce the amount of sample entering each reaction

Both options come with trade-offs.

To understand why, it helps to think about the concept of a sample’s molecule budget.

Once DNA is extracted, the sample contains a finite number of molecules. Every PCR reaction spends part of that budget. When the sample is divided across assays, the available molecules must be divided as well.

As the molecule budget is split across more reactions, each measurement observes a smaller fraction of the available molecules. And at low molecule counts, this has important statistical consequences.

PCR precision depends on molecule counts

At low molecule counts, PCR measurements are governed by Poisson sampling statistics. The expected sampling variation follows a simple relationship:

Where:

• N = number of molecules entering the reaction

• CV = coefficient of variation caused purely by stochastic sampling

This means measurement precision is fundamentally determined by how many molecules are sampled.

The number of molecules entering the reaction depends on two factors:

Where:

• C = concentration of DNA (copies per µL)

• V = sample volume entering the reaction

Even perfectly optimized PCR chemistry cannot overcome noise if too few molecules are sampled.

Example: sampling noise at fixed input volume

Assume a reaction uses 5 µL of DNA input.

Sample concentration	Molecules entering reaction	Expected Poisson CV
200 copies/µL	1000	~3%
20 copies/µL	100	~10%
2 copies/µL	10	~32%

As molecule counts decrease, stochastic variation increases rapidly. This effect becomes especially important in workflows involving rare variants, low-abundance targets, or limited DNA samples.

What happens when samples are split across assays?

When multiple targets must be measured, laboratories often run separate PCR assays. This creates two possible scenarios depending on how much DNA is available.

If enough DNA is available

Each assay can receive the full input volume.

Number of assays	Input per assay	Total sample consumed
1	5 µL	5 µL
2	5 µL	10 µL
5	5 µL	25 µL
10	5 µL	50 µL

Precision per assay remains unchanged.

However, the total sample required increases proportionally.

For many workflows this quickly becomes impractical, especially when:

• DNA extraction yields are low

• samples are precious (clinical biopsies, forensic traces)

• replicates are required

If DNA input is limited

In many real workflows, the total DNA available per sample is constrained. In those cases the same molecular budget must be divided across assays.

Example: 5 µL total input available

Number of assays	Input per assay	Molecules per assay	Expected CV
1	5 µL	100	10%
2	2.5 µL	50	14%
5	1 µL	20	22%

Now each assay receives fewer molecules, which increases stochastic sampling noise.

The variance increases because the reaction is observing a smaller fraction of the molecular population

Why this matters in real workflows

Low-input DNA is common in many fields:

• liquid biopsy and rare variant detection

• forensic DNA analysis

• environmental DNA studies

• microbiome profiling

• limited clinical samples

In these settings, splitting samples across assays often forces difficult compromises:

• fewer targets per sample

• fewer replicates

• reduced measurement precision

Researchers frequently compensate by repeating experiments or increasing sequencing depth, which adds cost and time.

Multiplexing changes the equation

An alternative approach is to measure many targets in a single reaction.

When targets are multiplexed:

• the full molecular population remains in the reaction

• molecule sampling is maximized

• precision improves without consuming additional sample

Instead of dividing the DNA across assays, the assay design extracts more information from the same molecular input.

This is why high-multiplex measurement strategies have become increasingly important for modern molecular workflows.

Reaction volume and molecular sampling

PCR reaction design also influences how many molecules can be sampled.

Many PCR assays operate with relatively small input volumes, which can limit the number of molecules entering the reaction when DNA concentration is low.

For example, Hyperplex PCR (hpPCR) assays typically use:

• 5 µL of sample input

• in a 10 µL total PCR reaction

When higher molecular sampling is desired, the reaction volume can be scaled. For example:

Reaction format	Sample input	Total reaction volume
Standard hpPCR	5 µL	10 µL
Scaled reaction	25 µL	50 µL

The real hidden cost of splitting samples

The challenge of sample splitting is often framed as a workflow inconvenience.

But the deeper issue is statistical.

PCR precision ultimately depends on how many molecules enter the reaction. Splitting samples either consumes more material or reduces molecular sampling.

Both outcomes place limits on what can be measured reliably.

Understanding this constraint helps explain why many low-input workflows struggle with reproducibility—and why technologies that extract more information from the same input molecules are becoming increasingly valuable